Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the multi-gene regulatory molecular mechanism of Saudi Arabian flora against epilepsy based on data mining, network pharmacology and docking analysis. | Saudi Pharm J | 2023 | 37638220 | PubTator, text mining | PubMed |
| Emerging roles of cytosolic phosphoenolpyruvate kinase 1 (PCK1) in cancer. | Biochem Biophys Rep | 2023 | 37637941 | PubTator, text mining | PubMed |
| Pharmacophore-Based Machine Learning Model To Predict Ligand Selectivity for E3 Ligase Binders. | ACS Omega | 2023 | 37636935 | PubTator, text mining | PubMed |
| Ubiquitination Is a Novel Post-Translational Modification of VMP1 in Autophagy of Human Tumor Cells. | Int J Mol Sci | 2023 | 37629161 | PubTator, text mining | PubMed |
| Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies. | Cells | 2023 | 37626927 | PubTator, text mining | PubMed |
| A mutator-derived prognostic eRNA signature provides insight into the pathogenesis of breast cancer. | Exp Cell Res | 2023 | 37611728 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification and Prognostic Analysis of UBE2K in Hepatocellular Carcinoma: A Potential Target. | Crit Rev Eukaryot Gene Expr | 2023 | 37606163 | PubTator, text mining | PubMed |
| C-terminal sequence stability profiling in Saccharomyces cerevisiae reveals protective protein quality control pathways. | J Biol Chem | 2023 | 37595870 | PubTator, text mining | PubMed |
| m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. | Mol Cancer | 2023 | 37582735 | PubTator, text mining | PubMed |
| Identification of LncPVT1 and CircPVT1 as prognostic biomarkers in human colorectal polyps. | Sci Rep | 2023 | 37573419 | PubTator, text mining | PubMed |
| G4-QuadScreen: A Computational Tool for Identifying Multi-Target-Directed Anticancer Leads against G-Quadruplex DNA. | Cancers (Basel) | 2023 | 37568632 | PubTator, text mining | PubMed |
| A preliminary study of calcium channel-associated mRNA and miRNA networks in post-traumatic epileptic rats. | Sci Rep | 2023 | 37567882 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. | Nat Commun | 2023 | 37558718 | PubTator, text mining | PubMed |
| Polymerase iota (POLI) confers radioresistance of esophageal squamous cell carcinoma by regulating RAD51 stability and facilitating homologous recombination. | Cell Death Discov | 2023 | 37558683 | PubTator, text mining | PubMed |
| Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients. | Front Immunol | 2023 | 37554330 | PubTator, text mining | PubMed |
| Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration. | J Biomed Sci | 2023 | 37550658 | PubTator, text mining | PubMed |
| Specific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis. | Sci Rep | 2023 | 37550396 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Elucidates The Immune And Intratumor Microbes Characteristics Of Ubiquitination Subtypes In Lung Adenocarcinoma. | Transl Oncol | 2023 | 37549605 | PubTator, text mining | PubMed |
| Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease. | PLoS One | 2023 | 37549144 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=13